Neratinib Plus Chemotherapy Improved PFS in HER2+ Breast Cancer With CNS Involvement

Mashup Score:

Targeted Oncology - Neratinib plus capecitabine improved progression-free survival and time to intervention for central nervous system disease in patients with previously treated HER2-positive metastatic breast cancer

Targeted Oncology

The combination of neratinib and capecitabine improved progression-free survival and time to intervention for CNS disease in patients with previously treated HER2-positive metastatic breast cancer. https://t.co/K20kvpJWrw #breastcancer #bcsm

Read the full article here

Share this article

facebook twitter email

https://dev.mashupmd.com/neratinib-plus-chemotherapy-improved-pfs-in-her2-breast-cancer-with-cns-involvement-2/

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced bre...

posted 6 months

Source: The Lancet Oncology

Share this article

facebook twitter email

https://dev.mashupmd.com/veliparib-with-carboplatin-and-paclitaxel-in-brca-mutated-advanced-breast-cancer-brocade3-a-randomised-double-blind-placebo-controlled-phase-3-trial/

Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irra...

posted 6 months

Source: Journal of Clinical Oncology

Share this article

facebook twitter email

https://dev.mashupmd.com/accelerated-partial-breast-irradiation-compared-with-whole-breast-irradiation-for-early-breast-cancer-long-term-results-of-the-randomized-phase-iii-apbi-imrt-florence-trial/

FDA Provides Update on Breast Implant–Associated Lymphoma, Illness

posted 6 months

Source: OncLive